| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Aurinia Pharmaceuticals Inc.
13D/A
AUPH · 05156V102
|
4.4% |
8/26/2026
Event 8/20/2026
|
||||
| ILJIN SNT Co., Ltd. | 3.7% | |||||
| ILJIN Steel Co., Ltd. | 0.7% | |||||
| ILJIN GLS Co., Ltd. | 3.7% | |||||
| Sae Kyoung Huh | 0.4% | |||||
| Seoung Eun Huh | 0.1% | |||||
| Chin Kyu Huh | 4.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.